CClinicalTrials.gg
CompletedNCT06632015Updated Aug 22, 2025

Effect of DCS on Post-Endodontic Pain

An interventional study of Calcium Hydroxide (CH) and Diclofenac Sodium (DCS) in Post Endodontic Pain, sponsored by Mustafa Kemal University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Mustafa Kemal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jan 2024, registered Oct 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The aim of this randomized, triple-blind, parallel-group clinical trial was to evaluate the effects of calcium hydroxide (CH), diclofenac sodium (DCS), and their combination (CH+DCS) as intracanal medicaments on post-endodontic pain in mandibular molars diagnosed with symptomatic apical periodontitis. Ninety patients were randomly assigned to three groups (CH, DCS, or CH+DCS; n=30 each). Pain intensity was recorded using a 100 mm Visual Analog Scale (VAS) over 7 days following treatment, and the number of analgesic tablets taken was also recorded. Statistical analyses were performed using Kruskal-Wallis, Friedman, Wilcoxon signed-rank, and Chi-square tests, with significance set at 0.05. The null hypothesis stated that there would be no significant difference in post-endodontic pain among the groups.

Read the detailed description

This randomized, triple-blind, parallel-group clinical trial included 90 patients aged 18-60 years with a single mandibular molar diagnosed with symptomatic apical periodontitis. Sample size was calculated based on a priori power analysis to detect significant differences in post-endodontic pain, resulting in 30 participants per group.

All endodontic procedures were performed by a single clinician under local anesthesia. After tooth isolation and access cavity preparation, working length was determined using K-files and an apex locator, verified radiographically. Chemomechanical preparation was performed using Reciproc files according to canal dimensions. Irrigation was performed using 2.5% NaOCl and 17% EDTA, followed by canal drying.

Patients were randomly assigned to three groups according to the intracanal medicament:

Group 1 (CH): 1 g Calcium Hydroxide mixed with 1 mL distilled water Group 2 (DCS): 1 g Diclofenac Sodium mixed with 1 mL distilled water Group 3 (CH + DCS): 950 mg Calcium Hydroxide + 50 mg Diclofenac Sodium mixed with 1 mL distilled water The canals were sealed temporarily. Postoperative pain was recorded daily for 7 days using a 100 mm Visual Analog Scale (VAS). Patients also recorded the number of analgesic tablets taken. Pain assessments were conducted by a blinded researcher. For pain management, 400 mg ibuprofen was prescribed if needed, with contact support provided for severe pain.

At the second session, medicaments were removed, final irrigation was performed, canals were dried, and obturation was completed using a single-cone technique with gutta-percha and calcium silicate sealer. Teeth were restored with resin composite.

02

Conditions studied

  • Post Endodontic Pain

Keywords

  • Endodontics
  • Post-Endodontic Pain
  • Calcium Hydroxide
  • Diclofenac Sodium
  • Intracanal Medicament
  • Randomized Controlled Trial
03

In context

Lead sponsor

Mustafa Kemal University is the lead sponsor of 71 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 18 and 60 years
  • Systemically healthy (ASA I-II)
  • Diagnosed with symptomatic irreversible pulpitis or symptomatic apical periodontitis in mandibular molars (characterized by spontaneous pain or prolonged pain in response to cold test, and presence of percussion sensitivity)
  • Positive response to Electric Pulp Testing (EPT) and cold testing
  • Periapical Index (PAI) score of 1 or 2 according to Ørstavik et al. (1986)
  • Pre-operative pain level ≥50 mm on the Visual Analog Scale (VAS), which ranges from 0 (no pain) to 100 (most severe pain)

Exclusion criteria

Exclusion Criteria:

  • History of psychiatric disorders
  • Allergic reactions
  • Pregnancy
  • Use of analgesics within the previous 24 hours
  • Use of antibiotics within the last 3 months
  • Teeth with a sinus tract or history of abscess formation
  • Periodontal pocket depth >3 mm
  • Root resorption, root fractures, or ankylosis
  • Previous root canal treatment on the selected tooth
  • Teeth requiring prosthetic restoration
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Calcium Hydroxide (CH)

    Working length was determined using a size 15 K-file and an apex locator (Morita Root ZX, Tokyo, Japan) and confirmed radiographically. Chemomechanical preparation was performed as described in the protocol. After drying with paper points, 1 mL of distilled water mixed with 1 g calcium hydroxide powder was placed as the intracanal medicament.

    Drug: Calcium Hydroxide (CH)

  • Experimental
    Diclofenac Sodium (DCS)

    Procedures as in Arm 1. After drying with paper points, 1 mL of distilled water mixed with 1 g diclofenac sodium powder was placed as the intracanal medicament.

    Drug: Diclofenac Sodium (DCS)

  • Experimental
    Calcium Hydroxide + Diclofenac Sodium (CH+DCS)

    Procedures as in Arm 1. After drying with paper points, 1 mL of distilled water mixed with 950 mg calcium hydroxide powder and 50 mg diclofenac sodium powder was placed as the intracanal medicament.

    Drug: Calcium Hydroxide + Diclofenac Sodium (CH + DCS)

Interventions

  • DrugCalcium Hydroxide (CH)

    1 mL distilled water mixed with 1 g calcium hydroxide powder, placed into the root canals using a lentulo spiral.

  • DrugDiclofenac Sodium (DCS)

    1 mL distilled water mixed with 1 g diclofenac sodium powder, placed into the root canals using a lentulo spiral.

  • DrugCalcium Hydroxide + Diclofenac Sodium (CH + DCS)

    1 mL distilled water mixed with 950 mg calcium hydroxide powder and 50 mg diclofenac sodium powder, placed into the root canals using a lentulo spiral.

06

What researchers measure

Primary outcomes

  1. Post-Endodontic Pain

    Pre-operative (before treatment) and post-operative pain were assessed using the Visual Analog Scale (VAS), a 100 mm horizontal line with numerical values. Patients rated their pain on the VAS, and pain severity was categorized as follows: No pain (0 mm), mild pain (1-19 mm), moderate pain (20-49 mm), severe pain (50-79 mm), and very severe pain (80-100 mm). Post-operative pain measurements were taken on Days 1, 2, 3, 4, 5, 6, and 7 after intracanal medicament application.

    Time frame: Baseline and Days 1-7 post-treatment

07

Study locations

1 site
  • Hatay Mustafa Kemal University
    Hatay, Antakya, Turkey (Türkiye)
08

References and documents

Publications

  • Fidanoglu B, Tufenkci P, Sari M. The effects of calcium hydroxide and diclofenac sodium as root canal medicaments on post-endodontic pain: a double-blinded, parallel group, randomized controlled clinical trial. Odontology. 2025 Nov 9. doi: 10.1007/s10266-025-01252-9. Online ahead of print. PubMed 41206809 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect patient privacy and confidentiality.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06632015
Lead sponsor
Mustafa Kemal University
Responsible party
BÜŞRA FİDANOĞLU (Research Assistant, Mustafa Kemal University) — Principal investigator
First posted
Oct 8, 2024
Start date
Jan 22, 2024
Primary completion
May 17, 2024
Completion
May 24, 2024
Last update
Aug 22, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion